---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-006163"
form_type: "8-K"
ticker: "QCLS"
cik: "0001321834"
company_name: "Q/C TECHNOLOGIES, INC."
filed_at: "2024-02-13T23:59:59+00:00"
generated_at: "2026-06-06T03:09:03.941487+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# MyMD Pharmaceuticals effectuates 1-for-30 reverse stock split to maintain Nasdaq listing

## Summary
- Reverse stock split at 1-for-30 ratio effective Feb 14, 2024 at 4:05 p.m. EST.
- Outstanding shares reduced from ~62.7M to ~2.09M; authorized shares reduced from 500M to 16.67M.
- Common stock begins trading on split-adjusted basis Feb 15 under same ticker MYMD; new CUSIP 62856X201.
- Fractional shares rounded up to nearest whole share; proportional adjustments to warrants, preferred stock, and equity awards.
- Company states split is intended to maintain compliance with Nasdaq listing requirements.

## SEC filing metadata
- accession: 0001493152-24-006163
- form_type: 8-K
- ticker: QCLS
- cik: 0001321834
- company_name: Q/C TECHNOLOGIES, INC.
- filed_at: 2024-02-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.03, 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1321834/000149315224006163/0001493152-24-006163-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1321834/000149315224006163/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-006163
- JSON: https://secwatch.observer/filing/0001493152-24-006163.json
- Plain text: https://secwatch.observer/filing/0001493152-24-006163.txt

## Key facts
- Governance Changes
  Q/C TECHNOLOGIES, INC.: Certificate of Amendment filed to effect a 1-for-30 reverse stock split and reduce authorized shares from 500 million to 16,666,666 (effective 2024-02-14).
  - Change: charter amendment
  - Effective: 2024-02-14
  source text: On February 13, 2024, MyMD Pharmaceuticals, Inc. (the " Company ") announced that it had filed with the Secretary of State of the State of New Jersey a Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation (the " Charter Amendment ") to effect a 1-for-30 reverse stock split (the " Reverse Stock Split ") of the Company’s common stock, without par value (the " Common Stock "), effective as of 4:05 p.m. Eastern Standard Time on February 14, 2024 (the " Effective Time ").
  evidence_url: https://www.sec.gov/Archives/edgar/data/1321834/000149315224006163/0001493152-24-006163-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.